非侵入式脑机接口技术

Search documents
岩山科技:接待乌兹别克斯坦数字技术部部长一行,聚焦AI前沿技术突破
Quan Jing Wang· 2025-06-26 08:19
2025年6月20日,乌兹别克斯坦共和国数字技术部部长、国家首席信息官(CIO)谢尔马托夫·谢尔佐德 带领国家代表团莅临访问岩山科技(002195),上海岩山科技股份有限公司董事、常务副总经理陈代千 代表公司热情接待。 在人工智能、数字经济深刻重塑全球格局的背景下,此次访问紧密贴合我国提出的"数字丝绸之路"倡议 及乌兹别克斯坦共和国数字化转型战略目标,不仅彰显了乌方对我国科技企业的高度重视,更见证了岩 山科技硬核技术实力的稳步增长。 访问期间,代表团成员参观了岩山科技展厅前沿科技创新成果展陈,重点观摩了岩思类脑人工智能研究 院在非侵入式脑机接口技术上的重大突破,该技术已成功应用于操控《黑神话悟空》游戏,实现连续、 精准、全指令集的游戏操控,其部分人机交互性能已超越侵入式脑机接口。代表团还与岩山科技展厅陈 列的智能机器人展开了深度互动,此机器人搭载了RockAI最新研发的Yan1.3多模态通用大模型,该模型 可高效处理图文及语音等多模态信息,并能广泛适配于机器人、PC、手机等各类终端设备。此外,岩 山科技旗下智能驾驶公司Nullmax全栈自研的MaxDrive 辅助驾驶解决方案也引发了代表团的热切关注, 该方案 ...
从实验室走向真实需求 对话强脑科技创始团队成员张胜男:非侵入式脑机接口已在多场景落地
Mei Ri Jing Ji Xin Wen· 2025-06-17 12:10
Group 1 - The core belief is that non-invasive brain-computer interface (BCI) technology will have a profound impact on humanity, with Qiang Brain Technology emerging as a leader in the global BCI field, ranking second in financing scale [1][3] - The two common technical routes in the BCI field are invasive and non-invasive, with invasive solutions being more suitable for severe medical conditions but posing safety risks, while non-invasive technology is advancing to capture brain activity signals more accurately [3][4] - According to a Morgan Stanley report, the market value of BCIs in the medical field in the U.S. alone is estimated at $400 billion, indicating significant industry potential [3] Group 2 - Qiang Brain Technology, originating from Harvard University's innovation lab, focuses on solving real-life problems rather than solely on self-developed technologies, targeting areas such as rehabilitation and health for various groups including disabled individuals and children with attention deficits [4] - The non-invasive BCI technology can transform educational scenarios by personalizing learning experiences and integrating BCI technology into AI course designs, promoting interdisciplinary development [4] - In 2024, Qiang Brain Technology plans to launch a dexterous hand product, entering the embodied intelligence field, and has become a supplier for humanoid robot dexterous hands due to its superior sensitivity and responsiveness compared to traditional robotic solutions [4][5]
熵基科技(301330) - 301330熵基科技投资者关系管理信息20250617
2025-06-17 09:36
编号:2025-05 | 投资者关系活 | 特定对象调研分析师会议媒体采访业绩说明会新闻发布会 | | --- | --- | | 动类别 | 路演活动 现场参观其他() | | 参与单位名称 | 国泰海通证券、思达资本(Zeta Capital)、德摩资本(DM Capital) | | 时间 | 2025 年 6 月 17 日 10:00-12:00 | | 地点 | 熵基科技会议室 | | | 董事会秘书、副总经理:郭艳波 | | 上市公司接待 人员姓名 | 智能创新研究院院长:仲崇亮 | | | 战略投资部投资总监:陈川 | | | 公司工作人员带领投资者参观了公司展厅及研发实验室,对公司发展历程、主营业务、 | | | 主要产品等基本情况做了介绍,对公司当前研发方向进行了讲解。 | | | 随后与投资者进行交流,就投资者所关心的问题进行解答,主要交流内容如下: | | | 1.公司脑机相关业务的技术路径是什么?是基于什么样的考虑? | | | 答:当前脑机相关技术,主要分为侵入式与非侵入式。侵入式脑机接口需要通过颅骨钻 | | | 孔植入,存在一定的免疫排斥及长期的信号衰减的风险 ...
每周股票复盘:麦澜德(688273)进军泌尿男科市场或成新盈利点
Sou Hu Cai Jing· 2025-05-24 15:02
Core Viewpoint - The company is focusing on expanding its business in the urology sector, particularly in the treatment of prostate diseases, which is expected to become a new growth point in the next 2-3 years [1][3]. Group 1: Business Performance - As of May 23, 2025, the company's stock price closed at 28.7 yuan, up 1.16% from the previous week, with a total market capitalization of 2.87 billion yuan [1]. - The company ranks 101 out of 126 in the medical device sector and 4226 out of 5148 in the A-share market [1]. Group 2: Product and Market Strategy - The decline in gross margin for the pelvic floor business is attributed to the initial low margins of new product promotions, but margins are expected to gradually recover as system solutions and combination sales strategies are implemented [1][3]. - The company is focusing on non-invasive brain-computer interface technology for neurodegenerative diseases, targeting conditions such as Alzheimer's and Parkinson's, with plans to expand application scenarios [1][3]. Group 3: Overseas Expansion - The short-term goal for overseas business is to deepen penetration in the Asia-Pacific market, while the long-term strategy shifts from "product output" to "demand-driven" approaches [2][3]. - The promotion of the Kangmei Center is still in its early stages, facing challenges such as medical insurance reimbursement limitations, while establishing model centers in Jiangsu and Zhejiang [2][3]. Group 4: Sales Strategy - The company employs a unique sales strategy that combines serious medical consumption with consumer medical seriousness, utilizing a tiered distribution model in serious medical markets and a multi-faceted marketing approach in consumer medical markets [2][3].
【私募调研记录】观合资产调研麦澜德
Zheng Quan Zhi Xing· 2025-05-23 00:09
Group 1 - The core viewpoint of the article highlights that 麦澜德 is focusing on the male prostate disease market, which is expected to become a new growth point in the next 2-3 years [1] - 麦澜德's gross margin in the pelvic floor business has declined due to low margins from new product promotions, but it is anticipated to gradually recover and stabilize [1] - The company is concentrating on common scenarios such as stroke and neurological injury rehabilitation, with its pricing policy still in the improvement phase [1] Group 2 - 麦澜德 employs non-invasive brain-machine interface technology, targeting neurodegenerative diseases, strokes, and pediatric cerebral palsy, with plans to expand application scenarios in the future [1] - The short-term goal for overseas business is to deepen the Asia-Pacific market, while the medium to long-term goal shifts from "product output" to "demand-driven" [1] - Nearly half of the research and development investment is allocated to projects involving AI technology [1] Group 3 - The promotion of 康美中心 is still in its early stages, facing core challenges such as medical insurance pricing restrictions, insufficient market pricing mechanisms in hospitals, and consumer demand recognition [1] - The company adopts a tiered distribution model in the serious medical market and a multi-faceted marketing approach in the consumer medical market, emphasizing compliant promotion [1]
未知机构:今日小段子汇总202505071脑机接口央视新闻面对面-20250508
未知机构· 2025-05-08 02:20
今日小段子汇总20250507 1、脑机接口:央视新闻《面对面》栏目深度探访强脑科技(BrainCo),其为非侵入式脑机接口技术。 嘉事堂、狄耐克、麒盛科技 2、锦好医疗:网传公司AI助听器通过非侵入式脑机接口技术,能够实时采集用户的注意力、听觉疲劳度等脑电数 据,并结合深度神经网络算法优化语音信号处理。 (未证实) 3、军工(印巴):当地时间5月7日5时10 今日小段子汇总20250507 1、脑机接口:央视新闻《面对面》栏目深度探访强脑科技(BrainCo),其为非侵入式脑机接口技术。 嘉事堂、狄耐克、麒盛科技 2、锦好医疗:网传公司AI助听器通过非侵入式脑机接口技术,能够实时采集用户的注意力、听觉疲劳度等脑电数 据,并结合深度神经网络算法优化语音信号处理。 (未证实) 3、军工(印巴):当地时间5月7日5时10分左右,巴基斯坦三军新闻局发言人确认,迄今巴方击落5架印度战机,分 别为3架阵风、1架米格、1架苏-30。 中航成飞、通易航天、爱乐达 4、晨曦航空:公司长期以来专注于航空机电产品的研发、生产和销售,主要为国有大型军工企业及其他厂商配 套,最终用户主要为军方。 5、华伍股份:公司军工领域旗下有安德 ...